MB
HALO icon

MidFirst Bank’s Halozyme HALO Stock Holding History

MidFirst Bank’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2K Buy
347
+300
+638% +$20.5K ﹤0.01% 443
2026
Q1 		$3.04K Sell
47
-3,076
-98% -$217K ﹤0.01% 630
2025
Q4 		$3.16K Buy
+3,123
New +$210K ﹤0.01% 655

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MidFirst Bank's HALO Position: Q2 2026 in Review

MidFirst Bank increased its Halozyme (HALO) stake by 638% in Q2 2026, buying an estimated $20.5K and bringing the position to 347 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #443.

MidFirst Bank first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 528 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • MidFirst Bank held 347 shares of Halozyme worth $27.2K as of Q2 2026.
  • MidFirst Bank bought 300 Halozyme shares in Q2 2026, an estimated $20.5K.
  • Halozyme made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #443 holding.
  • MidFirst Bank first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • 528 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.